By Justin A. Varholick, Ph.D.
As we grow older theres an impending fear that we will slowly, but surely, begin to lose our vision. This slow loss of vision is clinically dubbed low vision and impacts more than 39 million Americans, costs $68 billion annually in direct health care costs, and is only growing in our population as baby boomers enter the at-risk age of 65 and older. Magnifiers can often be used to help people with acute issues of low vision, but are often inconvenient and frustrating. More serious issues of low vision such as cataracts, age-related macular degeneration, glaucoma, and diabetic retinopathy require advanced treatment and surgery. For example, cataracts can be improved or reversed by removing the cloudy lens and replacing it with an artificial one. Such surgeries are not always ideal, or convenient, and further contribute to the already hefty direct health care costs. But, a recent breakthrough by Japanese scientists, in correcting blurry vision, might reverse this bleak future.
Old cells can become new againOur story begins around the mid-20th century, in 1958. A young and aspiring scientist, named John Gurdon, was studying frogs at the University of Oxford in England. Not everyone thought Gurdon would end up actually becoming a scientist. In his early days his school master thought such a career was far-fetched for Gurdon. Indeed, he ranked last in his Biology class out of 250 students. Yet despite such poor grades, Gurdon found himself studying frogs at Oxford and earning a doctoral degree in Biology. And his studies would surprisingly lead to a breakthrough in vision, and likely many other issues in human health, like Parkinsons Disease, heart disease, and spinal cord injury.
At the time Gurdon was trying to test an age-old theory on cell development. Many scientists before him discovered that cells the smallest unit of life begin without a clear fate in the early stages of an embryo. Then as the cell develops, their fate becomes more clear. They become cells of the heart, of the brain, the kidneys, the stomach, the spinal cord, or the eyes. But they cannot go back to a time when they had no fate, or specialization. The cells can only develop in one direction, from no destiny, to a clear path, then to a mature adult cell; like one found in the heart. But you just cant take a heart cell and start the process over, maybe turning it into a brain cell.
In disagreement with this theory, Gurdon did a simple experiment. He knew that a tadpole has more adult cells than a frog egg. A tadpole has gills, a heart, eyes, etc., while a frog egg simply does not. So, he cut open the tadpole and removed a single cell from the intestine; an intestinal cell. He then cut open the intestinal cell and removed its nucleus; the seed of the cell carrying all the DNA. Very carefully, he did the same with the frog egg, and finally replaced the nucleus of the frog egg with the nucleus of the intestinal cell. According to the age-old theory, the intestinal nucleus should stop normal development of the frog egg. But thats not what happened.
Instead, the new frog egg continued to develop normally, becoming a tadpole that later became an adult frog. Gurdon thought this was unbelievably odd, and so did everyone else in science. After many more experiments doing the exact same procedure (i.e., replication), it seemed that what he saw was a real, replicable fact. For some reason the nucleus of the intestinal cell was able to reverse itself to have no fate and slowly develop into any other adult cell. The seed from the intestine somehow could become the seed of a heart, brain, kidney, or even an eye cell and of course, an intestinal cell too.
After many more experiments testing the same theory, on many more animals, it seemed the theory was true, but it just didnt work for mammals. Given that the same effect could not be repeated in a mammal, some believed this discovery did not apply to humans. But they were wrong.
The discovery of induced pluripotent stem cellsAlmost 45 years later, around the start of the millennium, Shinya Yamanaka and Kazutoshi Takahashi began running experiments that would translate Gurdons findings to humans. Born after Gurdons findings were already published and well known, Yamanaka and Takahashi grew up in a world in which the fact that old cells can become new again was widely knowna solid foundation for further hypotheses, experiments, and discovery. So, the scientists set out to do what no one had before: turn adult skin cells of mice into new cells without a clear fate.
Yamanaka, the lead investigator of the study, shared a similar early history with Gurdon. He first became a medical doctor in Japan but was frustrated by his inability to quickly remove small human tumors taking over an hour rather than the typical 10 minutes. Senior doctors gave him the nickname Jamanaka, a Japanese pun for the word jama meaning obstacle. He then found himself earning a PhD in pharmacology and becoming a post-doctoral scientist, but spent more time caring for mice than doing actual research. Frustrated again, his wife suggested he just become a practicing physician. Despite her advice, Yamanaka applied to become an Assistant Professor at Nara Institute of Science and Technology, in Japan, and won everyone over with his fantastical ideas of investigating embryonic stem cells; the cells without a clear fate.
Then the persistence paid off when Yamanaka with his assistant, Takahashi discovered how to induce adult skin cells from mice to return to an embryonic, or stem cell, state without a clear fate. They began their experiments knowing that gene transcription factors proteins that turn genes on and off were responsible for keeping embryonic cells in a state without a clear fate. They thought that by turning specific genes on and off with these factors, they could turn back time and make an adult cell embryonic again. So, they tried many different combinations of gene transcription factors and ultimately discovered that 4 specific ones were enough to induce an adult skin cell to a mouse to become an embryonic cell. Because these re-newed embryonic cells, or stem cells, originally came from adult cells they came up with a new name, induced pluripotent stem cell. Broken down, induced pluripotent stem cells means that the cell was induced to become pluripotent pluri meaning several, like plural, and potent meaning very powerful (and stem meaning to have the ability to turn into any cell in the body).
These induced pluripotent cells were thought to be very powerful indeed and scientists across the globe were excited by this great discovery. They had visions of taking a persons skin or blood, forming them into induced pluripotent cells, and then using them to grow a new liver or new parts of the brain. Laboratories across the world confirmed the results by repeating the experiment.
Human stem cells Just repeating the experiments in mice, or frogs, was not enough. They needed to begin making induced pluripotent stem cells from humans. Enter scientists from the University of Wisconsin-Madison. The lead scientist, James Thomson was already well known for deriving primate embryonic cells from rhesus monkeys in 1995 and the first human embryonic cell line in 1998. In fact, Thomsons accomplishment of isolating embryonic cells from monkeys was the first sound evidence that it was possible to do the same for humans. Such discoveries placed him on the forefront in ethical considerations for research using human embryos and the most obvious scientist to lead the path toward making induced pluripotent stem cells from humans.
Thomsons team made the first human derived induced pluripotent stem cells from adult skin, with Yamanaka as a co-scientist. They followed the same general principles set by Yamanaka, who did the procedure with mouse skin cells. Importantly to Thomson, this discovery helped to relieve some ethical controversy with using human embryos to make human stem cells. By being able to induce adult human skin to become pluripotent stem cells, much research on human stem cells could be done without human embryos albeit research with human embryos remains necessary.
Yet more important to the discussion at hand, the ability to induce human skin to become pluripotent stem cells placed us on the edge of a breakthrough. With some clinical trials in humans, the fantasy of growing a new liver, heart, or eye was more a reality than ever before.
The start of human trials In 2012, around the time both Gurdon and Yamanaka were presented with the Nobel Prize in Physiology and Medicine for their work leading to induced pluripotent stem cells, human clinical trials were beginning in Japan. The first clinical trial was for age-related macular degeneration, an eye condition leading to blindness. Unfortunately, this trial was quickly terminated when Yamanaka and his team identified small gene mutations in the transplanted induced pluripotent stem cells from the first patient. Although the procedure did cure the patient of macular degeneration, these small gene mutations worried the scientists because they could lead to tumor development.
But recently with the introduction of an inducible suicide gene that can signal cells with abnormal growth to die, human trials are starting up again. In October of 2018, Japanese scientists began trials with Parkinsons disease, a brain disease related to a shortage of neurons producing dopamine. Scientists took cells from the patients, made them into induced pluripotent stem cells, guided them to develop into dopamine producing cells, and then deposited them in the dopamine centers of the brain through surgery. The outcome is promising since similar procedures in monkeys have been successful.
Other trials in Japan have also started, including spinal cord injury and one for replacing the cornea of the eye. Early results replacing damaged corneas with induced pluripotent stem cells, thereby correcting blurry vision, were just announced at the end of August. Although it will take more patients and safety checks before all humans can get induced pluripotent cells to correct their damaged eyes, malfunctioning brains, or broken spinal cords, Takahashi the post-doctoral scientist working with Yamanaka thinks it might happen as early as 2023. So, it looks like that in our lifetime we just might be able to stay young and enjoy retirement because of great breakthroughs in animal research.Note, EuroStemCell is a great resource for learning more about the ethics and research currently being done with stem cells derived from human embryos.
- Stem Cell Media Market with Competitive Analysis, New Business Developments and Top Companies: Thermo Fisher, STEMCELL Technologies - Owned - August 7th, 2020
- US government considers ethics of aborted tissue research - Pregnancy Help News - August 7th, 2020
- Plant Stem Cell Market 2020 Share Growing Rapidly With Latest Trends, Development, Revenue, Demand And Forecast To 2029 - Owned - August 7th, 2020
- Stem Cell Cartilage Regeneration Market Size, Global Analytical Overview, Key Players, Regional Demand, Trends and Forecast To 2026 - Bulletin Line - August 7th, 2020
- Covid-19 Impact on Global Stem Cell Assay Market Set Explosive Growth By 2019 2027 | Merck & Co., Thermo Fisher Scientific, GE Healthcare,... - August 7th, 2020
- Why cultivated meat is about to have its Tesla Roadster moment - Massive Science - August 7th, 2020
- Platelet Rich Plasma and Stem Cell Alopecia Treatment Market to Reach a Value of Approximately US$ 450.5 Mn by the End of 2026 - Science Examiner - August 6th, 2020
- Covid-19 Impact on 2021-2026 Stem Cell Manufacturing Market Segmentation, Analysis by Recent Trends, Development & Growth by Regions - Owned - August 6th, 2020
- Cell Transplantatio Therapy Market Global Research and Analysis 2020 - Owned - August 6th, 2020
- National STEM Scholars Announced for 2020 - PR Web - August 6th, 2020
- US government considers ethics of aborted tissue research - Catholic News Agency - August 6th, 2020
- Cell Viability Assays Market by Production Analysis, Current Trends 2024 Analysis of Regions with Top vendors, Market Dynamics, Types, Applications,... - August 6th, 2020
- Stem Cell Assay Market Study for 2020 to 2027 providing information on Key Players, Growth Drivers and Industry challenges - Bulletin Line - August 6th, 2020
- Allogeneic Stem Cells Market 2020-2024: Business Overview, Industry Size and Share, Opportunities, Impact of Drivers, Key Venders, Types, Applications... - August 5th, 2020
- Cancer Stem Cell Therapeutics Market Emerging Trends, Business Opportunities, Segmentation, Production Values, Supply-Demand, Brand Shares and... - August 5th, 2020
- IMAC Holdings Receives FDA Authorization to Initiate Clinical Study of Its Umbilical Cord-Derived Allogenic Mesenchymal Stem Cells for the Treatment... - August 5th, 2020
- Hematopoietic Stem Cell Transplantation (HSCT) Market 2020: Regen Biopharma Inc, China Cord Blood Corp, CBR Systems Inc, Escape Therapeutics Inc,... - August 5th, 2020
- BioTech Life Sciences Initiates New Study of Anti-Aging Formulas in Helping COVID-19 'Long-Haulers' and Those Suffering With Chronic Fatigue Syndrome... - August 5th, 2020
- COVID-19 Industry Impact On Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenue Develop Rapidly By 2019 2027 | Fibrocell Science,... - August 5th, 2020
- Nerve Repair and Regeneration Market worth $9.7 billion by 2025 - Exclusive Report by MarketsandMarkets - PRNewswire - August 5th, 2020
- Teams Working to Image Protein Clumps in Parkinson's Share $8.5M Prize - Parkinson's News Today - August 5th, 2020
- Placental Stem Cell Collection and Storage Market 2020 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2026 - Market... - August 4th, 2020
- Nerve Repair and Regeneration Market worth $9.7 billion by 2025 - Exclusive Report by MarketsandMarkets - PR Newswire UK - August 4th, 2020
- Cell Isolation Technology Market 2020 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2026 - Market Research Posts - August 4th, 2020
- Justin Thomas wins WGC-FedEx St. Jude Invitational and moves to No. 1 world ranking - Commercial Appeal - August 4th, 2020
- Latest Research on Autologous Cell Therapy Market 2020 by Application, Industry Share, End User with top players BioTime, Inc., BrainStorm Cell... - August 4th, 2020
- Stem Cell Assay Market to Witness Huge Growth By Top Players Merck & Co., Thermo Fisher Scientific, GE Healthcare, Agilent Technologies, Bio-Rad... - August 4th, 2020
- Stem Cell Cartilage Regeneration Market Outlook, Strategies, Challenges, Advancements, Geography Trends and Growth, Applications and Forecast 2026 -... - August 4th, 2020
- Cell Expansion Market Detailed Analysis of Current Industry Figures with Forecasts Growth By 2027 - CueReport - August 4th, 2020
- Cell Banking Outsourcing Market Size 2020 Industry Share, Strategies, Growth Analysis, Regional Demand, Revenue, Key Players and 2026 Forecast... - August 3rd, 2020
- 'Year of Preparations for the Next Fifty Years' will contribute to country's development process - Emirates News Agency - August 3rd, 2020
- Stem Cell Therapy Market Latest Trends, Development, Revenue, Demand And Forecast To 2022 - Market Research Correspondent - August 3rd, 2020
- Cell Proliferation Kit Market 2020-2026 analysis examined in new market research report with Focusing Key players like - BD Biosciences, GE... - August 3rd, 2020
- Research Antibodies Market 2020 to Witness Lucrative Growth in Coming Years with Top Key Players Abcam plc. Agilent Technologies, Merck KGaA - Market... - August 3rd, 2020
- Stem Cell Banking Outsourcing Market Research Report to 2026 COVID-19 Impact on Industry Size, Growth Share, Future Trends, Price, Top Key Players... - August 3rd, 2020
- Impact of Covid-19 on Stem Cell Banking Market 2020 | Enormous Growth with Recent Trends & Demand - Market Research Posts - August 3rd, 2020
- Animal Stem Cell Therapy Market to Reach US$ Million at xx% CAGR During the Forecast Period 2017 2025 - Bulletin Line - August 3rd, 2020
- Stem Cell Alopecia Treatment Market Share Worldwide Industry Growth, Size, Statistics, Opportunities and Forecasts up to 2027 - Owned - August 3rd, 2020
- How Airway Cells Work Together in Regeneration and Aging - Technology Networks - August 2nd, 2020
- Stem Cell Characterization Kits Market Research Report and Outlook by 2018 to 2026 - Owned - August 2nd, 2020
- Cell Expansion Market Set to Surpass US$XX Million by the end of 2017 2025 - Owned - August 2nd, 2020
- Global Multiple Myeloma Therapeutics Market 2020 | With Top Growing Companies & Coronavirus (COVID-19) Impact Analysis | Amgene, Inc., Celgene... - August 2nd, 2020
- Biotechnology Reagents Market Analysis and Forecast by Rapid Growth Rate 2020 Value Share Analysis by Regions, Industry Size, Key Insights till 2024 -... - August 2nd, 2020
- Personalized Cell Therapies Market to Witness Astonishing Growth by 2025 - Owned - August 2nd, 2020
- Why Superman 5 With Christopher Reeve Never Happened - Screen Rant - August 1st, 2020
- Research On Global Stem Cell Cartilage Regeneration Market (impact of COVID-19), Analysis, Overview, Growth Forecast, Top key players Anika... - August 1st, 2020
- Readers ask about antibody tests, chimeras and public health and privacy - Finance Brokerage - August 1st, 2020
- Gene variants and susceptibility to schizophrenia - The Hindu - August 1st, 2020
- How COVID-19 Pandemic Will Impact Australia & New Zealand Research Antibodies Market Business Opportunity, And Growth 2020-2026 Bulletin Line -... - August 1st, 2020
- FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adu - PharmiWeb.com - August 1st, 2020
- Animal Stem Cell Therapy Market Growth, Trends and Value Chain 2019-2025 - Owned - August 1st, 2020
- Global Allogeneic Stem Cell Therapy Market 2020 Research by Business Analysis, Growth Strategy and Industry Development to 2025 - Galus Australis - August 1st, 2020
- Global Stem Cell Assay Market 2020 Trends Analysis and Coronavirus (COVID-19) Effect Analysis | Key Players Market With COVID-19 Impact Analysis, In... - August 1st, 2020
- Cell Therapy Manufacturing Market is estimated to reach close to USD 11 Billion by 2030, predicts Roots Analysis - Market Research Posts - August 1st, 2020
- Global Cytokine Market 2020 Top Countries Data Industry Size, Share, Business Growth, Revenue, Trends, Market Demand Penetration and Forecast to By... - August 1st, 2020
- What's On The Ballot? A Summary Of The 12 State Propositions For November 2020 Election - KHTS Radio - July 31st, 2020
- Covid-19 Impact on Global Adipose Derived Stem Cell Therapy Market Strategies, Comparison, Shares, Demand, Supply, Challenges and Forecast to 2026 -... - July 31st, 2020
- Personalized Cell Therapies Market Trends, Outlook, and Opportunity Analysis up to 2021 focuses on major key players PCT Cell Therapy Services, LLC... - July 31st, 2020
- Stem Cell And Platelet Rich Plasma Prp Alopecia Therapies Market Size, Share, Types, Products, Trends, Growth, Applications and Forecast 2020 to 2027... - July 31st, 2020
- Limited Reporting of Adverse Events Tied to Regenerative Treatments Leaves Consumers Vulnerable - The Pew Charitable Trusts - July 31st, 2020
- How airway cells work together in regeneration and aging - Newswise - July 31st, 2020
- Global Animal Stem Cell Therapy Market 2020 Trends Analysis and Coronavirus (COVID-19) Effect Analysis | Key Players Market With COVID-19 Impact... - July 31st, 2020
- New Trends of Stem Cell Banking Market with Worldwide Industry Analysis to 2025 - Owned - July 31st, 2020
- Scientists to speed creation of pig vaccines - FarmingUK - July 30th, 2020
- Cell Culture Market Research Report by Product, by End User, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 - GlobeNewswire - July 30th, 2020
- Research report covers the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Forecasts and Growth, 2019-2025 - Market Research... - July 30th, 2020
- Trending Now: COVID-19 impact on 3D Cell Cultures Market Variables, Information, Emerging Trends, Analysis and Forecast 2020-2026 | Sigma, Lonza, 3D... - July 30th, 2020
- Global Covid-19 impact on Stem Cell Storage Market Insights and Upcoming Trends to Forecast till 2025| CCBC, CBR, ViaCord, Esperite, Vcanbio - Owned - July 30th, 2020
- Trending Now: Stem Cell Source Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026| BD Bioscience, Beckman Coulter, Ge... - July 30th, 2020
- Covid-19 Impact on Global Stem Cell Drugs Market by Technology, Solutions, Application, Price, Demand Analysis and Growth Opportunities to 2026 -... - July 30th, 2020
- Michael J. Fox Foundation Announces Winners of the "Ken Griffin Alpha-synuclein Imaging Competition" to Develop Game-Changing Tool for... - July 30th, 2020
- Cancer Stem Cell Therapeutics Market 2020 Global Trend, Segmentation and Opportunities Forecast To 2027 | Merck KGA, LONZA Group AG, Novartis, etc. -... - July 30th, 2020
- Cell Separation by Membrane Filtration Technology Market: In-depth Analysis of the Global Industry with Future Estimations till 2029 - Owned - July 30th, 2020
- Hematopoietic Stem Cell Transplantation Market Outlook | Recent Trends and Growth Forecast 2020 2027 - Owned - July 30th, 2020
- Mesoblast sees lasting need for COVID treatment beyond a vaccine - Sydney Morning Herald - July 30th, 2020
- UAE leads Covid-19 research in the Middle East - The National - July 30th, 2020
- Demand for Cryopreservation Equipment Market to Experience a Significant Dip in 2020, Influenced by COVID-19 Pandemic 2020-2029 | Thermo Fisher... - July 30th, 2020
- Plant Stem Cell Market Size, Share, Trends Analysis and Growth Forecast by Type and Application from 2020-2026 - Bulletin Line - July 30th, 2020
- Literature Review of Surgical Treatment in Idiopathic Full-Thickness M | OPTH - Dove Medical Press - July 29th, 2020
- Peripheral Nerve Repair Devices Market Research Report by Device, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of... - July 29th, 2020